Primary outcomes 6 months following therapy were; defect base fill (DBF) and defect width measurement (DW); secondary outcomes were clinical attachment level (CAL), pocket depth (PD), plaque index (PI ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound ... at McCormick Place at the American Society of Clinical Oncology’s annual conference, was ...

ABSTRACT: Individuals are always interacting and communicating with their environment, but there are many factors that affect the quality of this interaction and communication. These factors may be ...

A valid periodontitis diagnosis required Clinical Attachment Loss (CAL) and Pocket Probing Depth (PPD) assessments during full-mouth clinical examinations. The choice of meta-analysis model was based ...

At 17 months after Medicaid disenrollment, cumulative mortality was higher among those with early vs late disenrollment. HealthDay News — Loss of the Low-Income Subsidy (LIS) for drugs after ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...